Description
Ipamorelin, a pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, demonstrates remarkable potency and efficacy in stimulating growth hormone (GH) release, both in vitro and in vivo. This peptide emerged from extensive chemistry research, distinguished within a series of compounds derived from growth hormone-releasing peptide (GHRP)-1 by the absence of the central dipeptide Ala-Trp.
The unique specificity and effectiveness of ipamorelin position it as a promising candidate for future clinical investigations and research endeavors in the field of peptide therapeutics.
- Ipamorelin pentapeptide
- Growth hormone release stimulation
- Peptide research advancements
- GH releasing peptide derivatives
- Clinical development prospects